首页> 外文期刊>Analytical methods >A hydrogel sensor-based microfluidic platform for the quantitative and multiplexed detection of fertility markers for point-of-care immunoassays
【24h】

A hydrogel sensor-based microfluidic platform for the quantitative and multiplexed detection of fertility markers for point-of-care immunoassays

机译:基于水凝胶传感器的微流体平台,用于定量和复用检测的生育标志物用于护理点免疫测定

获取原文
获取原文并翻译 | 示例
           

摘要

We report a new microfluidics-based immunoassay platform based on 3D porous hydrogel particle sensors with planar rectangular geometries. Large numbers of sensors are made off-chip before being embedded into an injection molded microfluidic chip. This allows for both multiplexing and scalability of manufacturing processes. A specially designed adapter containing detection reagents and buffers is interfaced with a microfluidic chip allowing for an automated immunoassay to be performed. All antibody reagents required for the test are stored in a dried form on the chip, enabling stability for resource-limited settings. Fluorescence-based immunoassays are performed by a sequential flow of the sample, detection reagents and wash buffer over the sensors. A compact instrument that integrates microfluidic flow dispensing and pumping with highly sensitive array-based detection is used to conduct and read the assay. A multiplexed set of 4 important fertility-linked tests, beta-human chorionic gonadotropin ((beta-hCG), follicle stimulating hormone (FSH), luteinizing hormone (LH) and prolactin (PRL), that are commonly required at gynecology/IVF settings were developed and validated using discarded clinical samples. Detailed data on accuracy, precision, linearity, effects of interference and cross-reactivity have been studied, rendering the platform ready for clinical use.
机译:我们报告了基于3D多孔水凝胶颗粒传感器的新微流体的免疫测定平台,具有平面矩形几何形状。在嵌入注射模塑的微流体芯片之前,将大量传感器换上。这允许制造过程的复用和可扩展性。含有检测试剂和缓冲剂的特殊设计的适配器用微流体芯片接合,允许进行自动免疫测定。将测试所需的所有抗体试剂以干燥的形式储存在芯片上,使得能够稳定性地用于资源限制。通过样品,检测试剂和在传感器上的洗涤缓冲液的顺序流动进行荧光的免疫测定。一种紧凑的仪器,用于通过高灵敏度的基于阵列的检测进行微流体流量分配和泵送的紧凑型仪器来进行并读取测定。一种多路复用的4个重要的生育链接试验,β-人绒毛膜促性腺激素((β-HCG),卵泡刺激激素(FSH),酸丁激素(LH)和催乳素(PRL),在妇科/ IVF设置时通常需要通过丢弃的临床样本开发和验证。研究了关于精度,精度,线性度,干扰和交叉反应性的效果的详细数据,使平台准备好临床使用。

著录项

  • 来源
    《Analytical methods》 |2019年第12期|共12页
  • 作者单位

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

    Achira Labs 66B 13th Cross Rd JP Nagar Phase 3 Bangalore 560078 Karnataka India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号